Naba Alsaha Medical Services Co. reported a net profit rise to SAR 14.2 million in H1 2025, compared to SAR 13 million a year earlier.
Item | H1 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 96.27 | 98.09 | 1.9 % |
Net Income | 13.04 | 14.21 | 8.9 % |
Average Shares | 10.50 | 10.50 | - |
Earnings Per Share before unusual items (Riyal) | 1.24 | 1.35 | 8.9 % |
EPS (Riyal) | 1.24 | 1.35 | 8.9 % |
Item | H2 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 98.01 | 98.09 | 0.1 % |
Net Income | 8.78 | 14.21 | 61.9 % |
Average Shares | 10.50 | 10.50 | - |
Earnings Per Share before unusual items (Riyal) | 0.84 | 1.35 | 61.9 % |
EPS (Riyal) | 0.84 | 1.35 | 61.9 % |
The higher profit was mainly attributed to a 1.9% year-on-year (YoY) rise in revenues to approximately SAR 1.82 million, driven by a 4% increase in the number of patients, which positively impacted operating revenues.
Other contributing factors included a 128% YoY increase in other income to SAR 666,000, and a 48.7% YoY reduction in losses from investment in an associate by SAR 712,000.
On a sequential basis, net earnings rose 61.9% from SAR 8.78 million in H2 2024.
Shareholders’ equity, no minority interest, reached SAR 210.72 million by the end of the current period, compared to SAR 193.13 million in the prior-year period.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: